CSI Market
Sign In | Register

La Jolla Pharmaceutical (LJPC) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access LJPC Annual Income Statement →
The income statement data below highlights shifts in La Jolla Pharmaceutical's operating performance over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2022)
Q2 2022 		(Mar 31 2022) (Dec 31 2021) (Sep 30 2021) (Jun 30 2021)
Revenues
Revenue From Contract With Customer Including Assessed Tax10.51
Total Revenue10.54
Costs & Expenses
Cost of Goods and Services Sold1.69
Gross Profit8.85
Selling, Administration, Marketing9.76
Depreciation & Amortization0.40
Research and Development Expense0.15
Other Operating Expense / -Income0.01
Total operating costs including COS11.61
Operating income / -loss-1.07
Interest Expense3.55
Interest Expense, Borrowings2.40
Interest Expense, Other2.37
Interest Income0.00
Net Interest Expense / -Income3.55
Other loss / -income-7.09
Total costs & expenses8.07
Income & Taxes
Income / -loss before income taxes2.48
Income taxes expenses / -benefit0.02
Income after income taxes2.46
Net income / -loss of other equity0.00
Income / -loss from continuing operations2.46
Net income / -loss2.46
Income / -loss to shareholder2.46
EBIT6.02
EBITD6.04
EBITDA6.43
Earnings Per Share
Basic EPS (excl. extra items)0.10
Basic Net EPS0.10
Basic shares outstanding (Mill. of Units)25.35
Diluted Net EPS0.08
Diluted average shares (Mill. of Units)32.08
4 historic quarters locked

Sign in to unlock the full La Jolla Pharmaceutical income statement history.

Sign In Create Free Account

About LJPC Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.